Asterias Biotherapeutics is Drug Discovery in United States that focus on Asterias Biotherapeutics Inc business. Founded in 2012. They cover business area such as Asterias Biotherapeutics Inc, therapy, regenerative medicine, two core technology platform, cancer patient, immune system, their tumor, pluripotent stem cell platform, acute myelogenous leukemia, patient immune response, spinal cord injury, multiple sclerosis, stroke, United States.
2012
( 12 years old in 2024 )
Asterias Biotherapeutics Inc
-
6300 Dumbarton Circle
Fremont, CA 94555
United States
Private
Asterias Biotherapeutics Inctherapyregenerative medicinetwo core technology platformcancer patientimmune systemtheir tumorpluripotent stem cell platformacute myelogenous leukemiapatient immune responsespinal cord injurymultiple sclerosisstrokeUnited States
* We use standard office opening hours in near Asterias Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Asterias Biotherapeutics is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Asterias Biotherapeutics business is focusing on Asterias Biotherapeutics Inc.
Asterias Biotherapeutics headquarter office and corporate office address is located in 6300 Dumbarton Circle Fremont, CA 94555 United States.
Asterias Biotherapeutics was founded in United States.
In 2024, Asterias Biotherapeutics is currently focus on Asterias Biotherapeutics Inc sector.
Above is snippet of Google Trends for "Asterias Biotherapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Asterias Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
